AOI Medical, Inc. ("AOI")

 

TIDMAOI 
 
RNS Number : 6964Y 
AOI Medical, Inc. 
08 September 2009 
 
? 
AOI Medical, Inc. ("AOI") 
 
 
 
Press Information 
 
 
Cancellation of the special meeting of stockholders to be held on 8 September 
2009 
 
 
With reference to the announcement dated 1 September 2009 regarding the 
convening of a special meeting of stockholders to be held on 8 September 2009, 
it is further announced that the notice seeking to convene this meeting has been 
withdrawn. 
 
 
Proposal to cancel the admission of AOI's common stock to trading on AIM 
 
 
AOI intends to put to stockholders proposals to cancel the admission of its 
common stock to trading on AIM ("De-listing"). The Directors of AOI consider, 
inter alia, that the benefits of maintaining a listing on AIM are out-weighed by 
the costs incurred in maintaining such a listing and that AOI derives little 
benefit in terms of the liquidity in its shares or in its ability to raise new 
capital. In addition, the Directors do not believe that the market places an 
appropriate valuation on AOI or its shares. 
 
 
A circular to stockholders convening a special meeting of the stockholders of 
AOI at which the De-listing will be proposed will be despatched in due course. 
 
 
Board changes 
 
 
AOI announces that the following changes to the Board of AOI are to be 
implemented: 
 
1    William Christy has stood down as the Chief Executive Officer and as a 
Director of AOI with immediate 
 

     effect; 
 
2    Scott Baily has stood down as a Non-executive Director of AOI with 
immediate effect; and 
 
3    Ian Johnson is standing down as the Non-executive Chairman of AOI with 
effect from the De-listing. 
 
 
Commenting on these changes, Ian Johnson, Non-executive Chairman, said "William 
Christy and Scott Baily have played a significant role in the development of 
AOI. Bill led AOI from its inception and having recently raised $2.6 million in 
a difficult market, announced yesterday the completion of a 60 patient clinical 
trial. I would like to thank them for their contribution and wish them well for 
the future". 
 
 
Enquiries: 
 
 
+------------------------------------------------+--------------------------+ 
| Numis Securities Limited                       | Tel: [phone]     | 
|                                                | 1000                     | 
+------------------------------------------------+--------------------------+ 
| Nominated Adviser: Michael Meade / Brent Nabbs |                          | 
+------------------------------------------------+--------------------------+ 
| Corporate Broking: David Poutney               |                          | 
+------------------------------------------------+--------------------------+ 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 MSCCKFKQKBKDCCK